Canada and MENA PCR Diagnostic Kits Market
完整報告名稱與涵蓋範圍
Canada and MENA PCR Diagnostic Kits Market Research Report Forecast to 2032
報告摘要
CANADA AND MENA PCR Diagnostic Kits Market Research Report Forecast to 2032
Market Overview
PCR diagnostic kits are medical tools that utilize the polymerase chain reaction (PCR) method to identify and amplify specific DNA or RNA sequences, helping to detect and diagnose infections, genetic conditions, or other diseases. These kits typically contain reagents, primers, and enzymes necessary for the PCR process and are used in clinical laboratories and healthcare settings to analyze patient samples for the presence of pathogens or genetic markers.
The Canada and MENA PCR diagnostic kits market is burgeoning owing to factors such as rising incidences of chronic and infectious diseases and advancements in PCR-based technology products. However, a lack of skilled workers to interpret the data and the availability of alternative technologies are restraining the growth of the market. Nonetheless, the growing adoption of PCR diagnostic kits for early diagnosis and the increasing demand for personalized medicine in the coming years will present lucrative growth opportunities for the Canada and MENA PCR diagnostic kits market.
Market Segmentation
Based on the technology, the Canada and MENA PCR diagnostic kits market has been segmented into quantitative PCR (qPCR), and qualitative PCR. Quantitative PCR is further segmented into viral load quantification, gene expression.
Based on the application, the Canada and MENA PCR diagnostic kits market has been segmented into hemato-oncology, infectious diseases, thrombophilia, neurological disease, cardiovascular disease, and others.
In terms of end user, Canada and MENA PCR diagnostic kits market has been segmented into hospitals & clinics, diagnostic laboratories, and others.
Based on region, the PCR diagnostic kits market has been segmented into Canada and MENA. MENA is further segmented into UAE, Saudi Arabia, Kuwait, Iran, Qatar, Bahrain, Egypt, Morocco, Algeria, Jordan, and the Rest of MENA. MENA accounted for the largest market share of 53.12% in 2022 and is anticipated to reach USD 2,037.92 million by 2032, registering a faster CAGR of 6.85% during the forecast period.
Major Players
These include Bio-Rad Laboratories, Inc, BioMérieux , Thermo Fisher Scientific Inc, Agilent Technologies Inc, F. Hoffmann-La Roche Ltd, Merck KGaA , and QIAGEN.
授權報價
| Single User Price | $2,950 USD |
| Multi User Licence (up to 10 users) | $3,950 USD |
| Enterprisewide Price (Global Site License) | $5,250 USD |
目錄 Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 17
2 MARKET INTRODUCTION 19
2.1 DEFINITION 19
2.2 SCOPE OF THE STUDY 19
2.3 RESEARCH OBJECTIVE 19
2.4 MARKET STRUCTURE 20
3 RESEARCH METHODOLOGY 21
3.1 OVERVIEW 21
3.2 DATA FLOW 23
3.2.1 DATA MINING PROCESS 23
3.3 PURCHASED DATABASE: 24
3.4 SECONDARY SOURCES: 25
3.4.1 SECONDARY RESEARCH DATA FLOW: 26
3.5 PRIMARY RESEARCH: 27
3.5.1 PRIMARY RESEARCH DATA FLOW: 27
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED 28
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 29
3.6.1 REVENUE ANALYSIS APPROACH 29
3.7 DATA FORECASTING 30
3.7.1 DATA FORECASTING TECHNIQUE 30
3.8 DATA MODELING 31
3.8.1 MICROECONOMIC FACTOR ANALYSIS: 31
3.8.2 DATA MODELING: 32
3.9 TEAMS AND ANALYST CONTRIBUTION 34
4 MARKET DYNAMICS 36
4.1 INTRODUCTION 36
4.2 DRIVERS 36
4.2.1 INCREASING INCIDENCES OF INFECTIOUS DISEASES IN CANADA AND MENA 36
4.2.2 TECHNOLOGICAL ADVANCEMENTS IN PCR-BASED DIAGNOSTIC KITS 37
4.3 RESTRAINTS 38
4.3.1 DEARTH OF SKILLED PROFESSIONALS 38
4.4 OPPORTUNITY 39
4.4.1 GROWING ADOPTION OF PCR DIAGNOSTIC KITS FOR EARLY DIAGNOSIS 39
4.5 FUTURE TRENDS OF PCR-BASED DIAGNOSTIC KITS MARKET 39
5 MARKET FACTOR ANALYSIS 40
5.1 VALUE CHAIN ANALYSIS 40
5.1.1 R&D 41
5.1.2 MANUFACTURING 41
5.1.3 DISTRIBUTION AND SALES 41
5.1.4 POST-SALES MONITORING 42
5.2 PORTER’S FIVE FORCES MODEL 43
5.2.1 THREAT OF NEW ENTRANTS 43
5.2.2 BARGAINING POWER OF SUPPLIERS 43
5.2.3 THREAT OF SUBSTITUTES 44
5.2.4 BARGAINING POWER OF BUYERS 44
5.2.5 INTENSITY OF RIVALRY 44
5.3 IMPACT OF COVID-19 ON THE CANADA AND MENA PCR DIAGNOSTIC KITS MARKET 44
5.3.1 IMPACT ON SUPPLY CHAIN 44
5.3.2 IMPACT ON DEMAND AND SUPPLY 45
5.4 TOTAL NUMBER OF PCR TESTS PERFORMED IN CANADA AND MENA (2022) 45
6 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY 47
6.1 OVERVIEW 47
6.2 QUANTITATIVE PCR (QPCR) 48
6.2.1 VIRAL LOAD QUANTIFICATION 49
6.2.2 GENE EXPRESSION 49
6.2.3 OTHERS 50
6.3 QUALITATIVE PCR 50
7 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY APPLICATION 51
7.1 OVERVIEW 51
7.2 HEMATO-ONCOLOGY 53
7.3 INFECTIOUS DISEASES 53
7.3.1 COVID-19 54
7.3.2 FLU 55
7.3.3 TUBERCULOSIS AND DRUG-RESISTANT TBA 55
7.3.4 MENINGITIS 55
7.3.5 HIV 56
7.3.6 HEPATITIS 56
7.3.7 OTHERS 56
7.4 THROMBOPHILIA 57
7.5 NEUROLOGICAL DISEASE 57
7.6 CARDIOVASCULAR DISEASE 57
7.7 OTHERS 58
8 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY END USER 59
8.1 OVERVIEW 59
8.2 HOSPITALS & CLINICS 61
8.3 DIAGNOSTIC LABORATORIES 61
8.4 OTHERS 62
9 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY REGION 63
9.1 OVERVIEW 63
9.2 CANADA 64
9.3 MIDDLE EAST & NORTH AFRICA (MENA) 68
9.3.1 UAE 72
9.3.2 SAUDI ARABIA 74
9.3.3 KUWAIT 76
9.3.4 IRAN 78
9.3.5 QATAR 80
9.3.6 BAHRAIN 81
9.3.7 EGYPT 83
9.3.8 MOROCCO 85
9.3.9 ALGERIA 87
9.3.10 JORDAN 88
9.3.11 SYRIA 90
9.3.12 LEBANON 92
9.3.13 IRAQ 93
9.3.14 REST OF MIDDLE EAST & NORTH AFRICA 95
10 COMPETITIVE LANDSCAPE 98
10.1 INTRODUCTION 98
10.2 MARKET SHARE ANALYSIS, 2022 98
10.3 COMPETITOR DASHBOARD 99
10.4 PUBLIC PLAYERS STOCK SUMMARY 100
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL 100
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 101
10.6.1 PRODUCT LAUNCH 101
11 COMPANY PROFILES 102
11.1 THERMO FISHER SCIENTIFIC INC 102
11.1.1 COMPANY OVERVIEW 102
11.1.2 FINANCIAL OVERVIEW 103
11.1.3 PRODUCTS OFFERED 103
11.1.4 KEY DEVELOPMENTS 104
11.1.5 SWOT ANALYSIS 104
11.1.6 KEY STRATEGY 104
11.2 AGILENT TECHNOLOGIES, INC 105
11.2.1 COMPANY OVERVIEW 105
11.2.2 FINANCIAL OVERVIEW 106
11.2.3 PRODUCTS OFFERED 106
11.2.4 KEY DEVELOPMENTS 107
11.2.5 SWOT ANALYSIS 107
11.2.6 KEY STRATEGIES 107
11.3 F. HOFFMANN-LA ROCHE LTD 108
11.3.1 COMPANY OVERVIEW 108
11.3.2 FINANCIAL OVERVIEW 109
11.3.3 PRODUCTS OFFERED 109
11.3.4 KEY DEVELOPMENTS 110
11.3.5 SWOT ANALYSIS 110
11.3.6 KEY STRATEGIES 110
11.4 MERCK KGAA 111
11.4.1 COMPANY OVERVIEW 111
11.4.2 FINANCIAL OVERVIEW 112
11.4.3 PRODUCTS OFFERED 112
11.4.4 KEY DEVELOPMENTS 113
11.4.5 KEY STRATEGIES 113
11.5 QIAGEN 114
11.5.1 COMPANY OVERVIEW 114
11.5.2 FINANCIAL OVERVIEW 115
11.5.3 PRODUCTS OFFERED 116
11.5.4 KEY DEVELOPMENTS 116
11.5.5 KEY STRATEGIES 116
11.6 BIO-RAD LABORATORIES, INC 117
11.6.1 COMPANY OVERVIEW 117
11.6.2 FINANCIAL OVERVIEW 118
11.6.3 PRODUCTS OFFERED 118
11.6.4 KEY DEVELOPMENTS 119
11.6.5 SWOT ANALYSIS 119
11.6.6 KEY STRATEGIES 119
11.7 BIOMÉRIEUX 120
11.7.1 COMPANY OVERVIEW 120
11.7.2 FINANCIAL OVERVIEW 121
11.7.3 PRODUCTS OFFERED 121
11.7.4 KEY DEVELOPMENTS 122
11.7.5 SWOT ANALYSIS 123
11.7.6 KEY STRATEGIES 123
11.8 ENZO LIFE SCIENCES, INC 124
11.8.1 COMPANY OVERVIEW 124
11.8.2 FINANCIAL OVERVIEW 124
11.8.3 PRODUCTS OFFERED 125
11.8.4 KEY DEVELOPMENTS 125
11.8.5 KEY STRATEGIES 125
11.9 PROMEGA CORPORATION 126
11.9.1 COMPANY OVERVIEW 126
11.9.2 FINANCIAL OVERVIEW 126
11.9.3 PRODUCTS OFFERED 127
11.9.4 KEY DEVELOPMENTS 127
11.9.5 KEY STRATEGIES 127
11.10 PRIMERDESIGN LTD 128
11.10.1 COMPANY OVERVIEW 128
11.10.2 FINANCIAL OVERVIEW 128
11.10.3 PRODUCTS OFFERED 129
11.10.4 KEY DEVELOPMENTS 129
11.10.5 KEY STRATEGIES 129
12 DATA CITATIONS 130
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 32
TABLE 2 TOTAL NUMBER OF PCR TESTS PERFORMED IN CANADA AND MENA (2022) 45
TABLE 3 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 48
TABLE 4 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY REGION, 2019–2032 (USD MILLION) 48
TABLE 5 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 49
TABLE 6 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR VIRAL LOAD QUANTIFICATION, BY REGION, 2019–2032 (USD MILLION) 49
TABLE 7 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR GENE EXPRESSION, BY REGION, 2019–2032 (USD MILLION) 49
TABLE 8 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 50
TABLE 9 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR QUALITATIVE PCR, BY REGION, 2019–2032 (USD MILLION) 50
TABLE 10 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 52
TABLE 11 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR HEMATO-ONCOLOGY, BY REGION,
2019–2032 (USD MILLION) 53
TABLE 12 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY REGION,
2019–2032 (USD MILLION) 53
TABLE 13 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 54
TABLE 14 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR COVID-19, BY REGION, 2019–2032 (USD MILLION) 54
TABLE 15 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR FLU, BY REGION, 2019–2032 (USD MILLION) 55
TABLE 16 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR TUBERCULOSIS AND DRUG-RESISTANT TBA, BY REGION, 2019–2032 (USD MILLION) 55
TABLE 17 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR MENINGITIS, BY REGION, 2019–2032 (USD MILLION) 55
TABLE 18 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR HIV, BY REGION, 2019–2032 (USD MILLION) 56
TABLE 19 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR HEPATITIS, BY REGION, 2019–2032 (USD MILLION) 56
TABLE 20 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 56
TABLE 21 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR THROMBOPHILIA, BY REGION, 2019–2032 (USD MILLION) 57
TABLE 22 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR NEUROLOGICAL DISEASE, BY REGION, 2019–2032 (USD MILLION) 57
TABLE 23 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR CARDIOVASCULAR DISEASE, BY REGION, 2019–2032 (USD MILLION) 57
TABLE 24 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 58
TABLE 25 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 60
TABLE 26 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR HOSPITALS & CLINICS, BY REGION,
2019–2032 (USD MILLION) 61
TABLE 27 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2019–2032 (USD MILLION) 61
TABLE 28 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 62
TABLE 29 CANADA AND MENA: PCR DIAGNOSTIC KITS MARKET, BY REGION, 2019–2032 (USD MILLION) 63
TABLE 30 CANADA: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 65
TABLE 31 CANADA: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 65
TABLE 32 CANADA: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 66
TABLE 33 CANADA: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 66
TABLE 34 CANADA: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 67
TABLE 35 MENA: PCR DIAGNOSTIC KITS MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 70
TABLE 36 MENA: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 71
TABLE 37 MENA: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 71
TABLE 38 MENA: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 71
TABLE 39 MENA: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 72
TABLE 40 MENA: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 72
TABLE 41 UAE: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 72
TABLE 42 UAE: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 73
TABLE 43 UAE: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 73
TABLE 44 UAE: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 74
TABLE 45 UAE: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 74
TABLE 46 SAUDI ARABIA: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 74
TABLE 47 SAUDI ARABIA: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 75
TABLE 48 SAUDI ARABIA: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 75
TABLE 49 SAUDI ARABIA: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 76
TABLE 50 SAUDI ARABIA: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 76
TABLE 51 KUWAIT: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 76
TABLE 52 KUWAIT: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 77
TABLE 53 KUWAIT: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 77
TABLE 54 KUWAIT: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 77
TABLE 55 KUWAIT: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 78
TABLE 56 IRAN: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 78
TABLE 57 IRAN: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 78
TABLE 58 IRAN: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 79
TABLE 59 IRAN: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 79
TABLE 60 IRAN: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 79
TABLE 61 QATAR: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 80
TABLE 62 QATAR: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 80
TABLE 63 QATAR: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 80
TABLE 64 QATAR: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 81
TABLE 65 QATAR: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 81
TABLE 66 BAHRAIN: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 81
TABLE 67 BAHRAIN: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 82
TABLE 68 BAHRAIN: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 82
TABLE 69 BAHRAIN: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 83
TABLE 70 BAHRAIN: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 83
TABLE 71 EGYPT: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 83
TABLE 72 EGYPT: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 84
TABLE 73 EGYPT: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 84
TABLE 74 EGYPT: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 84
TABLE 75 EGYPT: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 85
TABLE 76 MOROCCO: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 85
TABLE 77 MOROCCO: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 85
TABLE 78 MOROCCO: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 86
TABLE 79 MOROCCO: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 86
TABLE 80 MOROCCO: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 86
TABLE 81 ALGERIA: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 87
TABLE 82 ALGERIA: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 87
TABLE 83 ALGERIA: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 87
TABLE 84 ALGERIA: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 88
TABLE 85 ALGERIA: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 88
TABLE 86 JORDAN: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 88
TABLE 87 JORDAN: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 89
TABLE 88 JORDAN: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 89
TABLE 89 JORDAN: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 89
TABLE 90 JORDAN: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 90
TABLE 91 SYRIA: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 90
TABLE 92 SYRIA: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 90
TABLE 93 SYRIA: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 91
TABLE 94 SYRIA: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 91
TABLE 95 SYRIA: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 91
TABLE 96 LEBANON: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 92
TABLE 97 LEBANON: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 92
TABLE 98 LEBANON: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 92
TABLE 99 LEBANON: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 93
TABLE 100 LEBANON: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 93
TABLE 101 IRAQ: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 93
TABLE 102 IRAQ: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 94
TABLE 103 IRAQ: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 94
TABLE 104 IRAQ: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019–2032 (USD MILLION) 94
TABLE 105 IRAQ: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 95
TABLE 106 REST OF MIDDLE EAST & NORTH AFRICA: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 95
TABLE 107 REST OF MIDDLE EAST & NORTH AFRICA: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019–2032 (USD MILLION) 95
TABLE 108 REST OF MIDDLE EAST & NORTH AFRICA: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019–2032 (USD MILLION) 96
TABLE 109 REST OF MIDDLE EAST & NORTH AFRICA: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, 96
TABLE 110 BY TYPE, 2019–2032 (USD MILLION) 96
TABLE 111 REST OF MIDDLE EAST & NORTH AFRICA: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019–2032 (USD MILLION) 97
TABLE 112 PUBLIC PLAYERS STOCK SUMMARY 100
TABLE 113 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL 100
TABLE 114 PRODUCT LAUNCH 101
TABLE 115 THERMO FISHER SCIENTIFIC INC: DISEASE PRODUCTS OFFERED 103
TABLE 116 AGILENT TECHNOLOGIES, INC: PRODUCTS OFFERED 106
TABLE 117 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 109
TABLE 118 MERCK KGAA: PRODUCTS OFFERED 112
TABLE 119 QIAGEN: PRODUCTS OFFERED 116
TABLE 120 BIO-RAD LABORATORIES, INC: PRODUCTS OFFERED 118
TABLE 121 BIOMÉRIEUX: PRODUCTS OFFERED 121
TABLE 122 BIOMÉRIEUX: KEY DEVELOPMENTS 122
TABLE 123 ENZO LIFE SCIENCES, INC: PRODCUTS OFFERED 125
TABLE 124 PROMEGA CORPORATION: PRODUCTS OFFERED 127
TABLE 125 PRIMERDESIGN LTD: PRODCUTS OFFERED 129
LIST OF FIGURES
FIGURE 1 CANADA & MENA PCR DIAGNOSTIC KITS MARKET: STRUCTURE 20
FIGURE 2 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 36
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 37
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 38
FIGURE 5 VALUE CHAIN ANALYSIS OF THE CANADA AND MENA PCR DIAGNOSTIC KITS MARKET 40
FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: CANADA AND MENA PCR DIAGNOSTIC KITS MARKET 43
FIGURE 7 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, TECHNOLOGY SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION) 47
FIGURE 8 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2022 & 2032 (USD MILLION) 47
FIGURE 9 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET SHARE (%), BY TECHNOLOGY, 2022 48
FIGURE 10 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION) 51
FIGURE 11 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION) 52
FIGURE 12 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET SHARE (%), BY APPLICATION, 2022 53
FIGURE 13 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, END USER SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION) 59
FIGURE 14 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY END USER, 2022 & 2032 (USD MILLION) 60
FIGURE 15 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET SHARE (%), BY END USER, 2022 61
FIGURE 16 CANADA AND MENA: PCR DIAGNOSTIC KITS MARKET, BY REGION, 2022 & 2032 (USD MILLION) 63
FIGURE 17 CANADA AND MENA: PCR DIAGNOSTIC KITS MARKET SHARE (%), BY REGION, 2022 64
FIGURE 18 CANADA MARKET ANALYSIS: PCR DIAGNOSTIC KITS MARKET, 2019-2032 TREND ANALYSIS 64
FIGURE 19 CANADA MARKET ANALYSIS: PCR DIAGNOSTIC KITS MARKET, 2019-2032 (USD MILLION) 65
FIGURE 20 MENA MARKET ANALYSIS: PCR DIAGNOSTIC KITS MARKET, 2019-2032 TREND ANALYSIS 68
FIGURE 21 MENA: PCR DIAGNOSTIC KITS MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 69
FIGURE 22 MENA: PCR DIAGNOSTIC KITS MARKET SHARE (%), BY COUNTRY, 2022 70
FIGURE 23 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET PLAYERS: COMPETITIVE ANALYSIS, 2022 98
FIGURE 24 COMPETITOR DASHBOARD: CANADA AND MENA PCR DIAGNOSTIC KITS MARKET 99
FIGURE 25 THERMO FISHER SCIENTIFIC INC: FINANCIAL OVERVIEW SNAPSHOT 103
FIGURE 26 THERMO FISHER SCIENTIFIC INC: SWOT ANALYSIS 104
FIGURE 27 AGILENT TECHNOLOGIES, INC: FINANCIAL OVERVIEW SNAPSHOT 106
FIGURE 28 AGILENT TECHNOLOGIES, INC: SWOT ANALYSIS 107
FIGURE 29 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 109
FIGURE 30 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 110
FIGURE 31 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT 112
FIGURE 32 QIAGEN: FINANCIAL OVERVIEW SNAPSHOT 115
FIGURE 33 BIO-RAD LABORATORIES, INC: FINANCIAL OVERVIEW SNAPSHOT 118
FIGURE 34 BIO-RAD LABORATORIES, INC: SWOT ANALYSIS 119
FIGURE 35 BIOMÉRIEUX: FINANCIAL OVERVIEW SNAPSHOT 121
FIGURE 36 BIOMÉRIEUX: SWOT ANALYSIS 123
1
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們